Skip to main content
. 2022 Mar 3;16:833592. doi: 10.3389/fncel.2022.833592

TABLE 1.

Demographic and clinical characteristics of the participants.

G1 (n = 35) G0 (n = 17) HC (n = 28) F, t or χ2 value Post hoc t-tests or p values
Age (years) 30.86 ± 6.84 30.29 ± 8.05 30.14 ± 5.00 0.102 0.903a
Gender (male/female) 13/22 6/11 14/14 1.377 0.502b
Education (years) 14.51 ± 3.28 12.94 ± 3.46 14.61 ± 2.69 1.797 0.173a
Illness duration (months) 6.23 ± 4.63 6.94 ± 3.98 0.544 0.589c
HRSD-17 scores 22.69 ± 3.41 20.18 ± 2.67 0.89 ± 0.88 585.979 G1 > G0 > HC
Anxiety/somatization 7.31 ± 1.92 6.41 ± 1.66 0.39 ± 0.57 174.531 G1 > G0 > HC
Weight loss 0.80 ± 0.83 0.06 ± 0.24 0 18.741 G1 > G0, HC
Cognitive disturbances 3.71 ± 1.78 3.41 ± 1.50 0 64.213 G1, G0 > HC
Retardation symptoms 6.40 ± 1.42 6.76 ± 1.56 0.18 ± 0.39 253.030 G1, G0 > HC
Sleep disturbances 4.46 ± 1.42 3.53 ± 1.28 0.32 ± 0.55 103.570 G1 > G0 > HC

G1, MDD patients with gastrointestinal symptoms; G0, MDD patients without gastrointestinal symptoms; HC, healthy controls; HRSD-17, 17-item Hamilton Rating Scale for Depression.

aThe p value was obtained by analyses of variance.

bThe p value was obtained by a chi-square test.

cThe p value was obtained by two-sample t tests.